世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

欧州のバイオフォトニクス市場予測 2019-2027年

EUROPE BIOPHOTONICS MARKET FORECAST 2019-2027

 

出版社 出版年月電子版価格 ページ数
Inkwood Research
インクウッドリサーチ
2019年1月US$1,250
シングルユーザライセンス(印刷不可PDF)
94

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートは欧州のバイオフォトニクス市場を分析・予測したInkwood Researchの市場調査報告書です。

Overview

KEY FINDINGS
The European market for biophotonics is thriving at a CAGR of 9.81% throughout the forecasting years of 2019-2027. The high growth rate of the geriatric population within the region will increase the frequency of numerous chronic diseases which in turn are expected to propel the demand for biophotonics therapy during the forecasting years. The UK, Germany, France, Italy, Spain and the Rest of Europe are considered for the market study.

MARKET INSIGHTS

Germany is expected to grasp the largest stock share of the biophotonics market by 2027 due to the country’s healthcare sector being funded by public institutions and government subsidies. Conversely, the United Kingdom is expected to grow at the best CAGR in the forecasting period due to the steady increase in the occurrence rate of chronic diseases in the country. The presence of leading medical device companies like GE Healthcare, Medtronic PLC, TE Connectivity, etc. in the region has turned the European region to stand at the second in the global biophotonics market.

COMPETITIVE INSIGHTS

There are major market players in the biophotonics market are Idex Corp., OpGen, Becton, Dickinson, & Company, Perkinelmer, Inc., Fisba AG, Medlumics SL, MKS Instrument, Olympus Corporation, Zecotek Photonics Inc., Oxford Instruments, Lumenis Ltd., Halma PLC, Thermo Fisher Scientific Inc., Hamamatsu Photonics K.K. and Carl Zeiss AG.



目次

Table of Contents

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. IN-VIVO TECHNOLOGY HOLDS THE LARGEST MARKET SHARE IN TERMS OF TECHNOLOGY
3.2.2. ANALYTICS SENSING IS THE FASTEST GROWING APPLICATION
3.2.3. MEDICAL DIAGNOSTICS ARE MAJORLY USED IN TERMS OF END USER
4. MARKET DYNAMICS
4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS
4.2.1. INCREASING GERIATRIC POPULATION
4.2.2. DAWN OF NANOTECHNOLOGY
4.2.3. GOVERNMENT INITIATIVES
4.2.4. INCREASING DEMAND FOR POINT OF CARE DEVICES
4.2.5. TECHNICAL ADVANCEMENT
4.3. MARKET RESTRAINTS
4.3.1. HIGH PRICE OF THE BIOPHOTONICS BIOPHOTONIC- BASED INSTRUMENTS
4.3.2. LACK OF PRECISE TRAINING AND KNOWLEDGE FOR USING BIOPHOTONICS TECHNOLOGY
4.4. MARKET OPPORTUNITIES
4.4.1. WIDE USE OF BIOPHOTONICS IN NON-MEDICAL SECTORS
4.5. MARKET CHALLENGES
4.5.1. SLUGGISH COMMERCIALIZATION RATE
5. MARKET BY TECHNOLOGY
5.1. IN-VITRO
5.2. IN-VIVO
6. MARKET BY APPLICATION
6.1. SURFACE IMAGING
6.2. LIGHT THERAPY
6.3. SEE-THROUGH IMAGING
6.4. SPECTRO MOLECULAR
6.5. MICROSCOPY
6.6. BIOSENSORS
6.7. ANALYTICS SENSING
6.8. INSIDE IMAGING (ENDOSCOPY)
6.9. OTHER APPLICATION
7. MARKET BY END USER
7.1. TESTS AND COMPONENTS
7.2. MEDICAL THERAPEUTICS
7.3. MEDICAL DIAGNOSTICS
7.4. NON-MEDICAL APPLICATION
8. KEY ANALYTICS
8.1. PORTER’S FIVE FORCES MODEL
8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE PRODUCT
8.1.3. BARGAINING POWER OF BUYERS
8.1.4. BARGAINING POWER OF SUPPLIERS
8.1.5. INTENSITY OF COMPETITIVE RIVALRY
8.2. KEY BUYING CRITERIA
8.2.1. TECHNOLOGY
8.2.2. APPLICATION
8.2.3. PRICE
8.2.4. EASE OF ADOPTION
8.3. KEY IMPACTING FACTORS
8.4. OPPORTUNITY MATRIX
8.5. VENDOR LANDSCAPE
9. GEOGRAPHICAL ANALYSIS
9.1. EUROPE
9.1.1. THE UNITED KINGDOM
9.1.2. FRANCE
9.1.3. GERMANY
9.1.4. ITALY
9.1.5. SPAIN
9.1.6. REST OF EUROPE
10. COMPETITIVE LANDSCAPE
10.1. MARKET SHARE ANALYSIS
10.2. COMPANY PROFILES
10.2.1. BECTON, DICKINSON, AND COMPANY
10.2.1.1. COMPANY OVERVIEW
10.2.1.2. PRODUCT PORTFOLIO
10.2.1.3. SCOT ANALYSIS
10.2.1.4. STRATEGIC INITIATIVES
10.2.2. CARL ZEISS AG
10.2.2.1. COMPANY OVERVIEW
10.2.2.2. PRODUCT PORTFOLIO
10.2.2.3. SCOT ANALYSIS
10.2.2.4. STRATEGIC INITIATIVES
10.2.3. FISBA AG
10.2.3.1. COMPANY OVERVIEW
10.2.3.2. PRODUCT PORTFOLIO
10.2.4. HALMA PLC
10.2.4.1. COMPANY OVERVIEW
10.2.4.2. PRODUCT PORTFOLIO
10.2.4.3. SCOT ANALYSIS
10.2.4.4. STRATEGIC INITIATIVES
10.2.5. HAMAMATSU PHOTONICS K.K.
10.2.5.1. COMPANY OVERVIEW
10.2.5.2. PRODUCT PORTFOLIO
10.2.5.3. SCOT ANALYSIS
10.2.5.4. STRATEGIC INITIATIVES
10.2.6. IDEX CORP.
10.2.6.1. COMPANY OVERVIEW
10.2.6.2. PRODUCT PORTFOLIO
10.2.6.3. SCOT ANALYSIS
10.2.7. LUMENIS LTD.
10.2.7.1. COMPANY OVERVIEW
10.2.7.2. PRODUCT PORTFOLIO
10.2.7.3. SCOT ANALYSIS
10.2.7.4. STRATEGIC INITIATIVES
10.2.8. MEDLUMICS SL
10.2.8.1. COMPANY OVERVIEW
10.2.8.2. PRODUCT PORTFOLIO
10.2.9. MKS INSTRUMENT
10.2.9.1. COMPANY OVERVIEW
10.2.9.2. PRODUCT PORTFOLIO
10.2.9.3. SCOT ANALYSIS
10.2.9.4. STRATEGIC INITIATIVES
10.2.10. OLYMPUS CORPORATION
10.2.10.1. COMPANY OVERVIEW
10.2.10.2. PRODUCT PORTFOLIO
10.2.10.3. SCOT ANALYSIS
10.2.10.4. STRATEGIC INITIATIVES
10.2.11. OPGEN
10.2.11.1. COMPANY OVERVIEW
10.2.11.2. PRODUCT PORTFOLIO
10.2.11.3. SCOT ANALYSIS
10.2.11.4. STRATEGIC INITIATIVES
10.2.12. OXFORD INSTRUMENTS
10.2.12.1. COMPANY OVERVIEW
10.2.12.2. PRODUCT PORTFOLIO
10.2.12.3. SCOT ANALYSIS
10.2.12.4. STRATEGIC INITIATIVES
10.2.13. PERKINELMER, INC.
10.2.13.1. COMPANY OVERVIEW
10.2.13.2. PRODUCT PORTFOLIO
10.2.13.3. SCOT ANALYSIS
10.2.13.4. STRATEGIC INITIATIVES
10.2.14. THERMO FISHER SCIENTIFIC INC.
10.2.14.1. COMPANY OVERVIEW
10.2.14.2. PRODUCT PORTFOLIO
10.2.14.3. SCOT ANALYSIS
10.2.14.4. STRATEGIC INITIATIVES
10.2.15. ZECOTEK PHOTONICS INC.
10.2.15.1. COMPANY OVERVIEW
10.2.15.2. PRODUCT PORTFOLIO
10.2.15.3. SCOT ANALYSIS
10.2.15.4. STRATEGIC INITIATIVE


TABLE LIST
TABLE 1 EUROPE BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
TABLE 2 EUROPE BIOPHOTONICS MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 3 EUROPE IN-VITRO MARKET 2019-2027 ($ MILLION)
TABLE 4 EUROPE IN-VIVO MARKET 2019-2027 ($ MILLION)
TABLE 5 EUROPE BIOPHOTONICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 6 EUROPE SURFACE IMAGING MARKET 2019-2027 ($ MILLION)
TABLE 7 EUROPE LIGHT THERAPY MARKET 2019-2027 ($ MILLION)
TABLE 8 TYPES OF SEE THROUGH IMAGING SYSTEMS
TABLE 9 EUROPE SEE-THROUGH IMAGING MARKET 2019-2027 ($ MILLION)
TABLE 10 EUROPE SPECTRO MOLECULAR MARKET 2019-2027 ($ MILLION)
TABLE 11 TYPES OF MICROSCOPY
TABLE 12 EUROPE MICROSCOPY MARKET 2019-2027 ($ MILLION)
TABLE 13 EUROPE BIOSENSORS MARKET 2019-2027 ($ MILLION)
TABLE 14 EUROPE ANALYTICS SENSING MARKET 2019-2027 ($ MILLION)
TABLE 15 CAPSULE ENDOSCOPY IN THE MARKET
TABLE 16 EUROPE INSIDE IMAGING (ENDOSCOPY) MARKET 2019-2027 ($ MILLION)
TABLE 17 EUROPE OTHER APPLICATION MARKET 2019-2027 ($ MILLION)
TABLE 18 EUROPE BIOPHOTONICS MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 19 EUROPE TESTS AND COMPONENTS MARKET 2019-2027 ($ MILLION)
TABLE 20 EUROPE MEDICAL THERAPEUTICS MARKET 2019-2027 ($ MILLION)
TABLE 21 EUROPE MEDICAL DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
TABLE 22 EUROPE NON-MEDICAL APPLICATION MARKET 2019-2027 ($ MILLION)
TABLE 23 EUROPE BIOPHOTONICS MARKET BY COUNTRY 2019-2027 ($ MILLION)

FIGURES LIST
FIGURE 1 EUROPE BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
FIGURE 2 EUROPE BIOPHOTONICS MARKET SHARE BY TECHNOLOGY 2018 & 2027 (%)
FIGURE 3 EUROPE BIOPHOTONICS MARKET BY IN-VITRO 2019-2027 ($ MILLION)
FIGURE 4 EUROPE BIOPHOTONICS MARKET BY IN-VIVO 2019-2027 ($ MILLION)
FIGURE 5 EUROPE BIOPHOTONICS MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 6 EUROPE BIOPHOTONICS MARKET BY SURFACE IMAGING 2019-2027 ($ MILLION)
FIGURE 7 EUROPE BIOPHOTONICS MARKET BY LIGHT THERAPY 2019-2027 ($ MILLION)
FIGURE 8 EUROPE BIOPHOTONICS MARKET BY SEE-THROUGH IMAGING 2019-2027 ($ MILLION)
FIGURE 9 EUROPE BIOPHOTONICS MARKET BY SPECTRO MOLECULAR 2019-2027 ($ MILLION)
FIGURE 10 EUROPE BIOPHOTONICS MARKET BY MICROSCOPY 2019-2027 ($ MILLION)
FIGURE 11 EUROPE BIOPHOTONICS MARKET BY BIOSENSORS 2019-2027 ($ MILLION)
FIGURE 12 EUROPE BIOPHOTONICS MARKET BY ANALYTICS SENSING 2019-2027 ($ MILLION)
FIGURE 13 EUROPE BIOPHOTONICS MARKET BY INSIDE IMAGING (ENDOSCOPY) 2019-2027 ($ MILLION)
FIGURE 14 EUROPE BIOPHOTONICS MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)
FIGURE 15 EUROPE BIOPHOTONICS MARKET SHARE BY END USER 2018 & 2027 (%)
FIGURE 16 EUROPE BIOPHOTONICS MARKET BY TESTS AND COMPONENTS 2019-2027 ($ MILLION)
FIGURE 17 EUROPE BIOPHOTONICS MARKET BY MEDICAL THERAPEUTICS 2019-2027 ($ MILLION)
FIGURE 18 EUROPE BIOPHOTONICS MARKET BY MEDICAL DIAGNOSTICS 2019-2027 ($ MILLION)
FIGURE 19 EUROPE BIOPHOTONICS MARKET BY NON-MEDICAL APPLICATION 2019-2027 ($ MILLION)
FIGURE 20 PORTER’S FIVE FORCES MODEL
FIGURE 21 KEY BUYING CRITERIA OF BIOPHOTONICS
FIGURE 22 KEY IMPACTING FACTORS OF BIOPHOTONICS
FIGURE 23 EUROPEAN GERIATRIC POPULATION OF 60 YEARS AND ABOVE 2000-2050 (MILLION)
FIGURE 24 THE UNITED KINGDOM BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
FIGURE 25 FRANCE BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
FIGURE 26 GERMANY BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
FIGURE 27 ITALY BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
FIGURE 28 POPULATION AGED 65 YEARS AND ABOVE IN SPAIN (% OF POPULATION)
FIGURE 29 SPAIN BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
FIGURE 30 REST OF EUROPE BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
FIGURE 31 MARKET SHARE OF BIOPHOTONICS MARKET 2018 (%)

List of Tables

TABLE LIST
TABLE 1 EUROPE BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
TABLE 2 EUROPE BIOPHOTONICS MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 3 EUROPE IN-VITRO MARKET 2019-2027 ($ MILLION)
TABLE 4 EUROPE IN-VIVO MARKET 2019-2027 ($ MILLION)
TABLE 5 EUROPE BIOPHOTONICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 6 EUROPE SURFACE IMAGING MARKET 2019-2027 ($ MILLION)
TABLE 7 EUROPE LIGHT THERAPY MARKET 2019-2027 ($ MILLION)
TABLE 8 TYPES OF SEE THROUGH IMAGING SYSTEMS
TABLE 9 EUROPE SEE-THROUGH IMAGING MARKET 2019-2027 ($ MILLION)
TABLE 10 EUROPE SPECTRO MOLECULAR MARKET 2019-2027 ($ MILLION)
TABLE 11 TYPES OF MICROSCOPY
TABLE 12 EUROPE MICROSCOPY MARKET 2019-2027 ($ MILLION)
TABLE 13 EUROPE BIOSENSORS MARKET 2019-2027 ($ MILLION)
TABLE 14 EUROPE ANALYTICS SENSING MARKET 2019-2027 ($ MILLION)
TABLE 15 CAPSULE ENDOSCOPY IN THE MARKET
TABLE 16 EUROPE INSIDE IMAGING (ENDOSCOPY) MARKET 2019-2027 ($ MILLION)
TABLE 17 EUROPE OTHER APPLICATION MARKET 2019-2027 ($ MILLION)
TABLE 18 EUROPE BIOPHOTONICS MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 19 EUROPE TESTS AND COMPONENTS MARKET 2019-2027 ($ MILLION)
TABLE 20 EUROPE MEDICAL THERAPEUTICS MARKET 2019-2027 ($ MILLION)
TABLE 21 EUROPE MEDICAL DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
TABLE 22 EUROPE NON-MEDICAL APPLICATION MARKET 2019-2027 ($ MILLION)
TABLE 23 EUROPE BIOPHOTONICS MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

FIGURES LIST
FIGURE 1 EUROPE BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
FIGURE 2 EUROPE BIOPHOTONICS MARKET SHARE BY TECHNOLOGY 2018 & 2027 (%)
FIGURE 3 EUROPE BIOPHOTONICS MARKET BY IN-VITRO 2019-2027 ($ MILLION)
FIGURE 4 EUROPE BIOPHOTONICS MARKET BY IN-VIVO 2019-2027 ($ MILLION)
FIGURE 5 EUROPE BIOPHOTONICS MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 6 EUROPE BIOPHOTONICS MARKET BY SURFACE IMAGING 2019-2027 ($ MILLION)
FIGURE 7 EUROPE BIOPHOTONICS MARKET BY LIGHT THERAPY 2019-2027 ($ MILLION)
FIGURE 8 EUROPE BIOPHOTONICS MARKET BY SEE-THROUGH IMAGING 2019-2027 ($ MILLION)
FIGURE 9 EUROPE BIOPHOTONICS MARKET BY SPECTRO MOLECULAR 2019-2027 ($ MILLION)
FIGURE 10 EUROPE BIOPHOTONICS MARKET BY MICROSCOPY 2019-2027 ($ MILLION)
FIGURE 11 EUROPE BIOPHOTONICS MARKET BY BIOSENSORS 2019-2027 ($ MILLION)
FIGURE 12 EUROPE BIOPHOTONICS MARKET BY ANALYTICS SENSING 2019-2027 ($ MILLION)
FIGURE 13 EUROPE BIOPHOTONICS MARKET BY INSIDE IMAGING (ENDOSCOPY) 2019-2027 ($ MILLION)
FIGURE 14 EUROPE BIOPHOTONICS MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)
FIGURE 15 EUROPE BIOPHOTONICS MARKET SHARE BY END USER 2018 & 2027 (%)
FIGURE 16 EUROPE BIOPHOTONICS MARKET BY TESTS AND COMPONENTS 2019-2027 ($ MILLION)
FIGURE 17 EUROPE BIOPHOTONICS MARKET BY MEDICAL THERAPEUTICS 2019-2027 ($ MILLION)
FIGURE 18 EUROPE BIOPHOTONICS MARKET BY MEDICAL DIAGNOSTICS 2019-2027 ($ MILLION)
FIGURE 19 EUROPE BIOPHOTONICS MARKET BY NON-MEDICAL APPLICATION 2019-2027 ($ MILLION)
FIGURE 20 PORTER’S FIVE FORCES MODEL
FIGURE 21 KEY BUYING CRITERIA OF BIOPHOTONICS
FIGURE 22 KEY IMPACTING FACTORS OF BIOPHOTONICS
FIGURE 23 EUROPEAN GERIATRIC POPULATION OF 60 YEARS AND ABOVE 2000-2050 (MILLION)
FIGURE 24 THE UNITED KINGDOM BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
FIGURE 25 FRANCE BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
FIGURE 26 GERMANY BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
FIGURE 27 ITALY BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
FIGURE 28 POPULATION AGED 65 YEARS AND ABOVE IN SPAIN (% OF POPULATION)
FIGURE 29 SPAIN BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
FIGURE 30 REST OF EUROPE BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
FIGURE 31 MARKET SHARE OF BIOPHOTONICS MARKET 2018 (%)

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る